Polymerase chain reaction analysis confirmed RSV infection. The blood cell count showed normocytic anaemia (haemoglobin, 7.3 g/dL), no leucocytosis, and a normal platelet count. A comprehensive ...

Researchers used cryo-EM, glycoproteomics, and modeling to generate the atomic structure of a fully glycosylated and membrane ...

Traditionally, the microbiologic diagnosis of RSV has been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays ...

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular telangiectasia type 2. Despite a steep fall-off in sales of RSV vaccine Arexvy last year ...

During one of the most active flu seasons in recent memory, infectious disease experts at Cancer Center say many of the ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...

and labeled with anti-RSV F protein/gold antibodies (colorized yellow) shedding from the surface of human lung epithelial A549 cells. · BioPharma Dive · National Institute of Allergy and ...

Phase 1 clinical trial results demonstrate BLB201's safety and ability to induce antibody and cell-mediated immune responses, positioning it as a promising candidate in the fight against RSV.

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...

A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds. A study by the University of Strathclyde and Public Health Scotland ...